INGN
Inogen Inc
Overview
Inogen manufactures and sells portable oxygen concentrators, stationary oxygen concentrators, airway clearance devices, and CPAP masks for patients with chronic respiratory conditions.
Inogen Inc is a Healthcare company operating in Medical Devices with a $174.1M market cap.
Most recent reported earnings: Q2 FY2026 (Aug 5, 2026).
21 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Management language signature
Disclosures
Investor Relations
Extracted from Unknown source, 2026-06-21.
Transcripts
Recent earnings calls
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
- Q1 FY2026Earnings2026-05-089 Q&A exchanges
- Q4 FY2025Earnings2026-02-246 Q&A exchanges
- Q3 FY2025Earnings2025-11-056 Q&A exchanges
- Q2 FY2025Earnings2025-08-088 Q&A exchanges
- Q1 FY2025Earnings2025-05-079 Q&A exchanges
- Q4 FY2024Earnings2025-02-258 Q&A exchanges
- Q3 FY2024Earnings2024-11-098 Q&A exchanges
- Q2 FY2024Earnings2024-08-0615 Q&A exchanges
- Q1 FY2024Earnings2024-05-079 Q&A exchanges
- Q4 FY2023Earnings2024-02-2712 Q&A exchanges
- Q3 FY2023Earnings2023-11-0710 Q&A exchanges
- Q2 FY2023Earnings2023-08-0710 Q&A exchanges
- Q1 FY2023Earnings2023-05-0513 Q&A exchanges
- Q4 FY2022Earnings2023-02-239 Q&A exchanges
- Q3 FY2022Earnings2022-11-0216 Q&A exchanges
- Q2 FY2022Earnings2022-08-0712 Q&A exchanges
- Q1 FY2022Earnings2022-05-079 Q&A exchanges
- Q4 FY2021Earnings2022-02-2420 Q&A exchanges
- Q3 FY2021Earnings2021-11-0613 Q&A exchanges
- Q2 FY2021Earnings2021-08-0418 Q&A exchanges
- Q1 FY2021Earnings2021-05-0419 Q&A exchanges
History
Earnings history
- Q2 FY20262026-08-05EPS— vs $-0.17—Rev— vs ——EODHD
- Q1 FY20262026-05-07EPS$-0.14 vs $-0.21+33.3%Rev$85.1M vs ——EODHD
- Q4 FY20252026-03-02EPS$-0.15 vs $-0.34+56.2%Rev$81.7M vs ——EODHD
- Q3 FY20252025-11-04EPS$-0.20 vs $-0.21+4.8%Rev$92.4M vs ——EODHD
- Q2 FY20252025-08-06EPS$-0.15 vs $-0.27+44.4%Rev$92.3M vs ——EODHD
- Q1 FY20252025-05-04EPS$-0.11 vs $-0.25+56.0%Rev$82.3M vs ——EODHD
- Q4 FY20242025-02-24EPS$-0.24 vs $-0.49+51.0%Rev$80.1M vs ——EODHD
- Q3 FY20242024-11-06EPS$-0.25 vs $-0.49+49.0%Rev$88.8M vs ——EODHD
- Q2 FY20242024-08-05EPS$-0.24 vs $-0.55+56.4%Rev$88.8M vs ——EODHD
- Q1 FY20242024-05-06EPS$-0.62 vs $-0.76+18.4%Rev$78.0M vs ——EODHD
- Q4 FY20232024-02-26EPS$-1.14 vs $-0.62-83.9%Rev$75.9M vs ——EODHD
- Q3 FY20232023-11-06EPS$-0.55 vs $-0.49-12.2%Rev$84.0M vs ——EODHD
- Q2 FY20232023-08-06EPS$-0.42 vs $-0.59+28.8%Rev$83.6M vs ——EODHD
- Q1 FY20232023-05-03EPS$-0.88 vs $-0.81-8.6%Rev$72.2M vs ——EODHD
- Q4 FY20222023-02-22EPS$-0.20 vs $-0.57+64.9%Rev$88.1M vs ——EODHD
- Q3 FY20222022-11-01EPS$-0.42 vs $-0.420.0%Rev$105.4M vs ——EODHD
- Q2 FY20222022-08-03EPS$-0.15 vs $-0.37+59.5%Rev$103.4M vs ——EODHD
- Q1 FY20222022-05-04EPS$-0.62 vs $-0.51-21.6%Rev$80.4M vs ——EODHD
- Q4 FY20212022-02-23EPS$-1.01 vs $-0.73-38.4%Rev$76.4M vs ——EODHD
- Q3 FY20212021-11-03EPS$0.53 vs $-0.26+100.0%Rev$93.1M vs ——EODHD
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q2 FY2026 | 2026-08-05 | — | $-0.17 | — | — | — | — | EODHD |
| Q1 FY2026 | 2026-05-07 | $-0.14 | $-0.21 | +33.3% | $85.1M | — | — | EODHD |
| Q4 FY2025 | 2026-03-02 | $-0.15 | $-0.34 | +56.2% | $81.7M | — | — | EODHD |
| Q3 FY2025 | 2025-11-04 | $-0.20 | $-0.21 | +4.8% | $92.4M | — | — | EODHD |
| Q2 FY2025 | 2025-08-06 | $-0.15 | $-0.27 | +44.4% | $92.3M | — | — | EODHD |
| Q1 FY2025 | 2025-05-04 | $-0.11 | $-0.25 | +56.0% | $82.3M | — | — | EODHD |
| Q4 FY2024 | 2025-02-24 | $-0.24 | $-0.49 | +51.0% | $80.1M | — | — | EODHD |
| Q3 FY2024 | 2024-11-06 | $-0.25 | $-0.49 | +49.0% | $88.8M | — | — | EODHD |
| Q2 FY2024 | 2024-08-05 | $-0.24 | $-0.55 | +56.4% | $88.8M | — | — | EODHD |
| Q1 FY2024 | 2024-05-06 | $-0.62 | $-0.76 | +18.4% | $78.0M | — | — | EODHD |
| Q4 FY2023 | 2024-02-26 | $-1.14 | $-0.62 | -83.9% | $75.9M | — | — | EODHD |
| Q3 FY2023 | 2023-11-06 | $-0.55 | $-0.49 | -12.2% | $84.0M | — | — | EODHD |
| Q2 FY2023 | 2023-08-06 | $-0.42 | $-0.59 | +28.8% | $83.6M | — | — | EODHD |
| Q1 FY2023 | 2023-05-03 | $-0.88 | $-0.81 | -8.6% | $72.2M | — | — | EODHD |
| Q4 FY2022 | 2023-02-22 | $-0.20 | $-0.57 | +64.9% | $88.1M | — | — | EODHD |
| Q3 FY2022 | 2022-11-01 | $-0.42 | $-0.42 | 0.0% | $105.4M | — | — | EODHD |
| Q2 FY2022 | 2022-08-03 | $-0.15 | $-0.37 | +59.5% | $103.4M | — | — | EODHD |
| Q1 FY2022 | 2022-05-04 | $-0.62 | $-0.51 | -21.6% | $80.4M | — | — | EODHD |
| Q4 FY2021 | 2022-02-23 | $-1.01 | $-0.73 | -38.4% | $76.4M | — | — | EODHD |
| Q3 FY2021 | 2021-11-03 | $0.53 | $-0.26 | +100.0% | $93.1M | — | — | EODHD |
Source: EODHD. INGN reported actuals as published; sparse fields render as —.
Track Record
SampleSpoken Alpha tracks INGN's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters but stock falls 60% of the time
SampleWhen a company consistently beats but the stock doesn't react, consensus is usually set too low or the buy-side number is materially above sell-side. Watch for guidance walk-downs ahead of the print.
Raised guidance 8 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
Quarterly beats & misses
Sample| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $4.28 | $3.20 | +33.8% | -0.2% | +2.7% |
| Q4 FY2026 | $4.28 | $3.17 | +34.9% | +2.2% | +4.4% |
| Q3 FY2026 | $4.45 | $3.19 | +39.5% | +0.4% | -0.5% |
| Q2 FY2026 | $4.38 | $3.24 | +35.3% | -3.5% | -1.4% |
| Q1 FY2025 | $4.38 | $3.26 | +34.3% | -3.8% | -5.0% |
| Q4 FY2025 | $4.27 | $3.36 | +27.0% | +0.6% | -0.1% |
| Q3 FY2025 | $4.30 | $3.31 | +30.0% | -8.0% | -8.1% |
| Q2 FY2025 | $4.51 | $3.54 | +27.4% | +1.9% | +2.0% |
| Q1 FY2024 | $4.86 | $3.47 | +40.1% | -4.6% | -2.1% |
| Q4 FY2024 | $4.27 | $3.29 | +29.7% | -5.6% | -3.5% |
Guidance change history
Sample- Q1 FY2026Raised2026-04-15
- Q4 FY2026Raised2026-13-15
- Q3 FY2026Raised2026-10-15
- Q2 FY2026Raised2026-07-15
- Q1 FY2025Raised2025-04-15
- Q4 FY2025Raised2025-13-15
- Q3 FY2025Raised2025-10-15
- Q2 FY2025Raised2025-07-15
Top executives
SampleSpoken Alpha builds an accountability record per executive — how the person's own guidance, language, and reactions have evolved across every call they've appeared on. The one-liners below are illustrative placeholder data pending the deviation v1 work. Click any name for the full role timeline and call appearance history.
- Kevin Raymond Merrill SmithCEO1 yr 6 mono recorded callsCurrentSample
CEO since 2024 • 5/8 beats (63%) • last call held guidance Q1 FY2026
- Jason Andrew RichardsonCFO2 mono recorded callsCurrentSample
CFO since 2026 • 2/2 beats (100%) • last guidance cut Q3 FY2026
- Michael J BourqueCFO1 yr 4 mo8 callsCurrentSample
CFO since 2025 • 3/4 beats (75%) • last call held guidance Q1 FY2026
- Mary E WrightVP, Chief Accounting Officer11 mono recorded callsCurrentSample
OTHER_C_SUITE since 2025 • 2/4 beats (50%) • last call held guidance Q3 FY2026
- Gregoire RamadeChief Commercial Officer2 yr 5 mono recorded callsCurrentSample
OTHER_C_SUITE since 2024 • 4/8 beats (50%) • last call held guidance Q3 FY2026
- Boyer Jennifer M YiEVP Entrprs Enblmnt, Ch HR Off11 mono recorded callsCurrentSample
DIVISION_HEAD since 2025 • 2/4 beats (50%) • last call held guidance Q3 FY2026
Peers
Other companies in Healthcare
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
For developers and AI agents
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for INGN.
$ curl https://api.spokenalpha.com/v1/companies/INGNFAQ
Frequently asked about INGN
Where can I find Inogen Inc's (INGN) earnings call transcripts?
Spoken Alpha indexes INGN's earnings call transcripts at https://spokenalpha.com/companies/INGN. Each call links to attributed speakers and parsed analyst Q&A. Inogen Inc's own investor relations page is at https://investor.inogen.com/.
When was Inogen Inc's most recent earnings call?
Inogen Inc (INGN) held its most recent earnings call on 2026-05-08, covering fiscal Q1 2026.
What sector is INGN in?
Inogen Inc (INGN) operates in the Healthcare sector (Medical Devices industry).